Zachary Clayton
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vascular Stiffness | 9 | 2023 | 414 | 2.410 |
Why?
| Cardiovascular Diseases | 7 | 2023 | 1731 | 1.740 |
Why?
| Eggs | 5 | 2021 | 30 | 1.570 |
Why?
| Inflammation | 12 | 2023 | 2485 | 1.460 |
Why?
| Glucose Intolerance | 2 | 2021 | 137 | 1.220 |
Why?
| Cellular Senescence | 3 | 2023 | 153 | 1.200 |
Why?
| Arteries | 4 | 2023 | 249 | 1.200 |
Why?
| Aorta | 5 | 2023 | 394 | 1.130 |
Why?
| Diet | 6 | 2020 | 1075 | 1.120 |
Why?
| Elastin | 2 | 2023 | 78 | 1.040 |
Why?
| Aging | 10 | 2024 | 1624 | 1.000 |
Why?
| Exercise | 6 | 2023 | 1644 | 0.970 |
Why?
| Diet, Western | 2 | 2021 | 66 | 0.940 |
Why?
| Spermidine | 1 | 2024 | 18 | 0.910 |
Why?
| Flavonols | 1 | 2023 | 11 | 0.910 |
Why?
| Vascular Diseases | 2 | 2023 | 231 | 0.890 |
Why?
| Motor Activity | 4 | 2024 | 643 | 0.850 |
Why?
| Polyketides | 1 | 2022 | 3 | 0.850 |
Why?
| Blood Glucose | 4 | 2019 | 1823 | 0.830 |
Why?
| Angiotensin II | 1 | 2022 | 91 | 0.780 |
Why?
| Spirostans | 1 | 2021 | 4 | 0.770 |
Why?
| Cognitive Dysfunction | 2 | 2022 | 273 | 0.770 |
Why?
| Pulse Wave Analysis | 7 | 2023 | 210 | 0.760 |
Why?
| Diet, High-Fat | 2 | 2021 | 225 | 0.720 |
Why?
| Doxorubicin | 2 | 2021 | 285 | 0.720 |
Why?
| Head-Down Tilt | 1 | 2020 | 5 | 0.720 |
Why?
| Endothelium, Vascular | 5 | 2023 | 850 | 0.720 |
Why?
| Bone Density | 2 | 2021 | 432 | 0.700 |
Why?
| Oxidative Stress | 4 | 2022 | 1086 | 0.680 |
Why?
| Physical Conditioning, Animal | 1 | 2021 | 196 | 0.680 |
Why?
| Antioxidants | 2 | 2023 | 530 | 0.660 |
Why?
| Prunus domestica | 1 | 2019 | 1 | 0.660 |
Why?
| Neoplasms | 2 | 2022 | 2106 | 0.650 |
Why?
| Mice | 14 | 2024 | 14934 | 0.640 |
Why?
| Carbon Dioxide | 1 | 2020 | 218 | 0.630 |
Why?
| Cholesterol, LDL | 2 | 2020 | 308 | 0.610 |
Why?
| Insulin Resistance | 4 | 2019 | 1079 | 0.610 |
Why?
| Housing, Animal | 1 | 2018 | 43 | 0.600 |
Why?
| Subcutaneous Fat | 1 | 2018 | 71 | 0.600 |
Why?
| Body Temperature Regulation | 1 | 2018 | 72 | 0.600 |
Why?
| Weight Loss | 1 | 2022 | 641 | 0.590 |
Why?
| Adipose Tissue, Brown | 1 | 2018 | 68 | 0.590 |
Why?
| Neovascularization, Pathologic | 1 | 2019 | 281 | 0.590 |
Why?
| Extracellular Matrix | 1 | 2021 | 436 | 0.580 |
Why?
| Animals | 21 | 2024 | 31884 | 0.580 |
Why?
| Colonic Neoplasms | 1 | 2019 | 222 | 0.570 |
Why?
| Medical Laboratory Science | 1 | 2016 | 7 | 0.560 |
Why?
| Mice, Inbred C57BL | 6 | 2024 | 4718 | 0.550 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2021 | 1138 | 0.550 |
Why?
| Physiology | 1 | 2016 | 9 | 0.550 |
Why?
| Feeding Behavior | 2 | 2019 | 574 | 0.550 |
Why?
| Students, Health Occupations | 1 | 2016 | 24 | 0.540 |
Why?
| Obesity | 6 | 2023 | 2525 | 0.540 |
Why?
| Reactive Oxygen Species | 4 | 2023 | 536 | 0.530 |
Why?
| Temperature | 1 | 2018 | 578 | 0.510 |
Why?
| Bread | 1 | 2015 | 4 | 0.500 |
Why?
| Cardiovascular System | 1 | 2016 | 126 | 0.500 |
Why?
| Writing | 1 | 2016 | 85 | 0.500 |
Why?
| Breakfast | 1 | 2015 | 14 | 0.500 |
Why?
| Physical Conditioning, Human | 1 | 2015 | 24 | 0.490 |
Why?
| Blood Pressure | 5 | 2023 | 1540 | 0.470 |
Why?
| T-Lymphocytes | 1 | 2022 | 1748 | 0.470 |
Why?
| Educational Measurement | 1 | 2016 | 261 | 0.470 |
Why?
| Energy Metabolism | 1 | 2018 | 730 | 0.430 |
Why?
| Resistance Training | 1 | 2015 | 113 | 0.430 |
Why?
| Adipose Tissue | 3 | 2022 | 558 | 0.420 |
Why?
| Anthracyclines | 2 | 2022 | 41 | 0.420 |
Why?
| Dietary Supplements | 4 | 2023 | 458 | 0.410 |
Why?
| Cholesterol | 3 | 2019 | 369 | 0.370 |
Why?
| Humans | 33 | 2023 | 115222 | 0.370 |
Why?
| Lipids | 3 | 2020 | 587 | 0.360 |
Why?
| Randomized Controlled Trials as Topic | 9 | 2023 | 1214 | 0.360 |
Why?
| Antineoplastic Agents | 1 | 2021 | 1882 | 0.350 |
Why?
| Bed Rest | 2 | 2020 | 15 | 0.340 |
Why?
| Clinical Competence | 1 | 2016 | 904 | 0.340 |
Why?
| Male | 17 | 2024 | 55814 | 0.320 |
Why?
| Muscle, Skeletal | 3 | 2024 | 1477 | 0.300 |
Why?
| Transcriptome | 2 | 2023 | 725 | 0.280 |
Why?
| Eating | 3 | 2023 | 347 | 0.280 |
Why?
| Random Allocation | 2 | 2016 | 336 | 0.240 |
Why?
| Young Adult | 7 | 2022 | 10520 | 0.230 |
Why?
| Apigenin | 1 | 2023 | 3 | 0.230 |
Why?
| Nitric Oxide | 3 | 2023 | 827 | 0.230 |
Why?
| Biomarkers | 5 | 2023 | 3422 | 0.230 |
Why?
| Hypertension | 2 | 2023 | 1060 | 0.220 |
Why?
| Synbiotics | 1 | 2023 | 1 | 0.220 |
Why?
| Pistacia | 1 | 2023 | 2 | 0.220 |
Why?
| Vitis | 1 | 2023 | 38 | 0.210 |
Why?
| Cardiotoxicity | 1 | 2022 | 28 | 0.210 |
Why?
| Probiotics | 1 | 2023 | 46 | 0.210 |
Why?
| Femur | 2 | 2021 | 193 | 0.210 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2023 | 119 | 0.210 |
Why?
| Antibiotics, Antineoplastic | 1 | 2022 | 109 | 0.200 |
Why?
| Drinking Water | 1 | 2022 | 64 | 0.190 |
Why?
| Macular Pigment | 1 | 2021 | 3 | 0.190 |
Why?
| Female | 14 | 2023 | 59720 | 0.190 |
Why?
| Insulin | 3 | 2019 | 2083 | 0.190 |
Why?
| Aged | 8 | 2023 | 19136 | 0.190 |
Why?
| Sweat | 1 | 2021 | 38 | 0.190 |
Why?
| Laboratories | 1 | 2022 | 95 | 0.190 |
Why?
| Methylamines | 1 | 2021 | 30 | 0.190 |
Why?
| Vision, Ocular | 1 | 2021 | 30 | 0.190 |
Why?
| Nitrates | 1 | 2021 | 72 | 0.180 |
Why?
| Triglycerides | 3 | 2020 | 472 | 0.180 |
Why?
| Amino Acids | 2 | 2021 | 451 | 0.180 |
Why?
| Sodium | 1 | 2021 | 183 | 0.180 |
Why?
| Rats, Wistar | 1 | 2021 | 369 | 0.170 |
Why?
| Honey | 1 | 2019 | 8 | 0.170 |
Why?
| Dietary Sugars | 1 | 2019 | 10 | 0.170 |
Why?
| Isoflavones | 1 | 2019 | 16 | 0.170 |
Why?
| Vitamins | 1 | 2021 | 151 | 0.170 |
Why?
| Carotid Arteries | 1 | 2021 | 183 | 0.170 |
Why?
| Running | 1 | 2022 | 209 | 0.170 |
Why?
| Adipokines | 1 | 2019 | 43 | 0.160 |
Why?
| Rats | 3 | 2023 | 4980 | 0.160 |
Why?
| Collagen | 1 | 2021 | 416 | 0.160 |
Why?
| Blood Vessels | 1 | 2020 | 180 | 0.160 |
Why?
| Adult | 11 | 2023 | 30711 | 0.160 |
Why?
| Postprandial Period | 1 | 2019 | 88 | 0.160 |
Why?
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2018 | 7 | 0.160 |
Why?
| Mice, 129 Strain | 1 | 2018 | 76 | 0.150 |
Why?
| Ceramides | 1 | 2018 | 94 | 0.150 |
Why?
| Hyperinsulinism | 1 | 2019 | 103 | 0.150 |
Why?
| Vitamin D | 1 | 2021 | 340 | 0.150 |
Why?
| Osteogenesis | 1 | 2019 | 183 | 0.150 |
Why?
| Hot Temperature | 1 | 2019 | 304 | 0.150 |
Why?
| Diabetes Mellitus, Type 2 | 2 | 2021 | 2098 | 0.140 |
Why?
| Cholesterol, Dietary | 1 | 2016 | 15 | 0.140 |
Why?
| Xanthophylls | 1 | 2016 | 11 | 0.140 |
Why?
| Polycystic Ovary Syndrome | 1 | 2019 | 141 | 0.140 |
Why?
| Ethanol | 1 | 2021 | 548 | 0.140 |
Why?
| Nutrition Policy | 1 | 2016 | 53 | 0.140 |
Why?
| Body Weight | 4 | 2023 | 875 | 0.140 |
Why?
| Time Factors | 2 | 2018 | 6157 | 0.130 |
Why?
| Critical Illness | 1 | 2021 | 645 | 0.130 |
Why?
| Analysis of Variance | 1 | 2019 | 1231 | 0.130 |
Why?
| Body Composition | 2 | 2020 | 586 | 0.130 |
Why?
| Hyperglycemia | 1 | 2019 | 294 | 0.130 |
Why?
| Circadian Rhythm | 1 | 2018 | 354 | 0.120 |
Why?
| Risk Factors | 3 | 2021 | 8658 | 0.120 |
Why?
| Diabetes Mellitus | 1 | 2023 | 909 | 0.120 |
Why?
| Overweight | 1 | 2019 | 475 | 0.120 |
Why?
| Liver | 1 | 2023 | 1688 | 0.120 |
Why?
| Brain | 2 | 2023 | 2378 | 0.120 |
Why?
| Mitochondria | 1 | 2020 | 750 | 0.120 |
Why?
| Middle Aged | 8 | 2023 | 26873 | 0.120 |
Why?
| Gene Expression | 1 | 2019 | 1424 | 0.120 |
Why?
| Adiposity | 1 | 2019 | 467 | 0.120 |
Why?
| Cognition | 1 | 2020 | 982 | 0.110 |
Why?
| Adolescent | 3 | 2022 | 17889 | 0.110 |
Why?
| Energy Intake | 3 | 2020 | 420 | 0.110 |
Why?
| Disease Models, Animal | 2 | 2019 | 3547 | 0.100 |
Why?
| Mice, Knockout | 1 | 2018 | 2586 | 0.100 |
Why?
| Cytokines | 1 | 2019 | 1843 | 0.100 |
Why?
| Chickens | 2 | 2021 | 179 | 0.090 |
Why?
| Cholesterol, HDL | 2 | 2020 | 185 | 0.080 |
Why?
| Chronic Disease | 1 | 2015 | 1594 | 0.080 |
Why?
| Heart Rate | 2 | 2023 | 705 | 0.080 |
Why?
| Cross-Over Studies | 2 | 2021 | 442 | 0.080 |
Why?
| Surveys and Questionnaires | 1 | 2016 | 4645 | 0.060 |
Why?
| Child | 1 | 2022 | 18468 | 0.060 |
Why?
| Nuts | 1 | 2023 | 12 | 0.050 |
Why?
| Butanols | 1 | 2022 | 8 | 0.050 |
Why?
| Body Mass Index | 2 | 2020 | 1968 | 0.050 |
Why?
| Superoxides | 1 | 2022 | 214 | 0.050 |
Why?
| Zeaxanthins | 1 | 2021 | 13 | 0.050 |
Why?
| Lutein | 1 | 2021 | 12 | 0.050 |
Why?
| Sweating | 1 | 2021 | 23 | 0.050 |
Why?
| Estrogens | 1 | 2023 | 317 | 0.050 |
Why?
| Observational Studies as Topic | 1 | 2021 | 90 | 0.050 |
Why?
| United States | 1 | 2016 | 12256 | 0.050 |
Why?
| Diet, Carbohydrate-Restricted | 1 | 2020 | 28 | 0.040 |
Why?
| Enteral Nutrition | 1 | 2021 | 157 | 0.040 |
Why?
| Rats, Zucker | 1 | 2019 | 26 | 0.040 |
Why?
| Fibroblast Growth Factors | 1 | 2021 | 162 | 0.040 |
Why?
| Phytoestrogens | 1 | 2019 | 15 | 0.040 |
Why?
| Osteocalcin | 1 | 2019 | 34 | 0.040 |
Why?
| Diet, Fat-Restricted | 1 | 2020 | 73 | 0.040 |
Why?
| Dietary Sucrose | 1 | 2019 | 45 | 0.040 |
Why?
| Vasodilation | 1 | 2022 | 417 | 0.040 |
Why?
| Immersion | 1 | 2019 | 5 | 0.040 |
Why?
| Anthropometry | 1 | 2020 | 182 | 0.040 |
Why?
| Exercise Test | 1 | 2022 | 545 | 0.040 |
Why?
| Oxygen Consumption | 1 | 2022 | 590 | 0.040 |
Why?
| Glucose Tolerance Test | 1 | 2019 | 344 | 0.040 |
Why?
| Rats, Sprague-Dawley | 1 | 2023 | 2216 | 0.040 |
Why?
| Respiration, Artificial | 1 | 2021 | 527 | 0.040 |
Why?
| C-Reactive Protein | 1 | 2019 | 363 | 0.040 |
Why?
| Critical Care | 1 | 2021 | 476 | 0.040 |
Why?
| Intensive Care Units | 1 | 2021 | 618 | 0.040 |
Why?
| Length of Stay | 1 | 2021 | 951 | 0.030 |
Why?
| Bone and Bones | 1 | 2019 | 282 | 0.030 |
Why?
| Osteoporosis | 1 | 2019 | 225 | 0.030 |
Why?
| Interleukin-6 | 1 | 2019 | 676 | 0.030 |
Why?
| Age Factors | 1 | 2021 | 2900 | 0.030 |
Why?
|
|
Clayton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|